Literature DB >> 7468933

Malignant melanoma. A unifying concept.

A B Ackerman.   

Abstract

Entities:  

Mesh：

Year:  1980        PMID： 7468933     DOI： 10.1097/00000372-198000240-00004

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN： 0193-1091            Impact factor:   1.533


× No keyword cloud information.
  6 in total

1.  Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression.

Authors:  Amy E Rose; Laura Poliseno; Jinhua Wang; Michael Clark; Alexander Pearlman; Guimin Wang; Eleazar C Vega Y Saenz de Miera; Ratna Medicherla; Paul J Christos; Richard Shapiro; Anna Pavlick; Farbod Darvishian; Jiri Zavadil; David Polsky; Eva Hernando; Harry Ostrer; Iman Osman
Journal:  Cancer Res       Date:  2011-02-22       Impact factor: 12.701

Review 2.  Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model.

Authors:  Holly S Greenwald; Erica B Friedman; Iman Osman
Journal:  Melanoma Res       Date:  2012-02       Impact factor: 3.599

3.  RSK1 activation promotes invasion in nodular melanoma.

Authors:  Amel Salhi; Joshua A Farhadian; Keith M Giles; Eleazar Vega-Saenz de Miera; Ines P Silva; Caitlin Bourque; Karen Yeh; Sagar Chhangawala; Jinhua Wang; Fei Ye; David Y Zhang; Eva Hernando-Monge; Yariv Houvras; Iman Osman
Journal:  Am J Pathol       Date:  2015-01-08       Impact factor: 4.307

4.  Malignant melanomas of the oral cavity: heterogeneity of pathological and clinical features.

Authors:  K Ohashi; T Kasuga; N Tanaka; S Enomoto; J Horiuchi; N Okada
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

5.  Study of the histopathological types of cutaneous melanoma in Palmas-TO from 2001 to 2011.

Authors:  Nilo Fernandes da Costa; Nurimar Conceição Fernandes; Myrlena Regina Machado Mescouto Borges
Journal:  An Bras Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.896

Review 6.  Treating advanced melanoma: current insights and opportunities.

Authors:  Michael Tronnier; Christina Mitteldorf
Journal:  Cancer Manag Res       Date:  2014-09-10       Impact factor: 3.989
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.